Rami Elghandour - 27 Feb 2025 Form 4 Insider Report for Arcellx, Inc. (ACLX)

Role
President, CEO and Chairman of the Board, Director
Signature
/s/ Michelle Gilson, as Attorney-in-Fact
Issuer symbol
ACLX
Transactions as of
27 Feb 2025
Net transactions value
$0
Form type
4
Filing time
27 Feb 2025, 16:10:43 UTC
Previous filing
26 Feb 2025
Next filing
29 Aug 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACLX Common Stock Award $0 +668,416 +448% $0.000000 817,602 27 Feb 2025 Direct F1
transaction ACLX Common Stock Award $0 +347,255 +42% $0.000000 1,164,857 27 Feb 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents vested shares of common stock issuable to the Reporting Person upon the partial achievement of performance criteria (measured as of December 31, 2024), as determined by the Issuer's compensation committee, under the Reporting Person's performance-based restricted stock award granted on June 9, 2021 pursuant the Issuer's 2017 Equity Incentive Plan and subsequently amended on December 7, 2021.
F2 Represents vested shares of common stock issuable to the Reporting Person upon the partial achievement of performance criteria (measured as of December 31, 2024), as determined by the Issuer's compensation committee, under the Reporting Person's performance-based restricted stock award granted on January 3, 2023 pursuant to the Issuer's 2022 Equity Incentive Plan.

Remarks:

President, CEO and Chairman of the Board